Company intelligence / Profile preview

Suzhou Xinda Biotechnology Co., Ltd.

Suzhou, Jiangsu Province / Jiangsu Sheng / Jiangsu / Suzhou City area, Chinaxindacorp.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Suzhou Xinda Biotechnology Co., Ltd. is an innovative Chinese biopharmaceutical company focused on the research, development, and commercialization of monoclonal antibody drugs for oncology and autoimmune diseases. The company has established significant strategic partnerships with Eli Lilly and others to expand its pipeline. Its lead assets include biosimilars such as Ipilimumab targeting CTLA-4 for various cancers, with several programs in early-to-mid clinical stages[7][10]. The company has raised substantial overseas capital ($232 million) from major investors including Fidelity Investments and Temasek[7].

Therapeutic areas: Oncology
Modalities: Monoclonal antibodies (mAbs)Small molecules (via partnerships)
Industry: Biotech

Drug pipeline

4 assets

rituximab

Commercial

Indications: Cancer

3 more assets in the full pipeline.

Request access →

Partnerships

Eli Lilly & Company [multiple co-development/commercialization agreements over past decade][5][7]

Beyond the preview

Go deeper on Suzhou Xinda Biotechnology Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suzhou Xinda Biotechnology Co., Ltd..

Explore the full profile